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were pulsed with the same peptide (exogenous path-
way). It is important to note that type B±specific T cells
recognized the same linear sequences bound to I-Ak as
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and Department of Pathology type A±specific T cells, but recognition by type B T cells
Washington University School of Medicine was restricted to a conformer dependent on the manner
St. Louis, Missouri 63110 in which the peptide was loaded. Type A±specific T
cells did not distinguish between these conformations,
recognizing the peptide-I-Ak complex loaded endoge-
nously or exogenously. Table 1 offers a comparison ofSummary
these two different epitopes generated from the same
linear sequence. Recent findings have confirmed thatMice expressing hen egg-white lysozyme (HEL) as a
the formation of multiple conformations of a single pep-transgene are unresponsive to immunization with the
tide-MHC complex can be observed in vitro (RabinowitzHEL protein. Profound tolerance was found even in
et al., 1997; Gyotoku et al., 1998). A prediction from thesituations where the amounts of I-Ak-peptide com-
finding of these two conformers is that some T cellsplexes was 100 or less per APC. Among the few T cells
directed to a type B conformer of a self-peptide-MHCthat escaped tolerance, we did not observe differential
responses to the different HEL epitopes, perhaps be- complex may escape negative selection when HEL is
cause of the very high sensitivity of the negative selec- presented as an autologous antigen by thymic APCs.
tion process. The same HEL transgenic mice that did These T cells could conceivably then have the potential
not respond to HEL responded to immunization with to react in peripheral tissues in conditions of inflamma-
the 46±61 peptide of HEL. These peptide-specific T tion that generate the peptide from the autologous an-
cells that escaped negative selection belonged to a tigen.
set that reacted with a particular conformer of the HEL The issue of differential sensitivity to tolerance of T
peptide-I-Ak (type B). The presence of type B reactive cell epitopes has been discussed previously (Gammon
T cells should be considered in autoimmunity. and Sercarz, 1989; Milich et al., 1989, 1991; Cibotti et
al., 1992; Fairchild et al., 1993; Joosten et al., 1994;
Cerasoli et al., 1995; Gapin et al., 1997; Shih et al., 1997;Introduction
Harrington et al., 1998). An epitope may be highly tolero-
genic because of a high level of expression by MHCThis paper examines tolerance to the protein antigen
molecules, perhaps reflecting its high binding affinityhen egg-white lysozyme (HEL). We evaluated the re-
for a class II molecule. In contrast, a second epitopesponse to HEL in the context of information now avail-
may be expressed at very limiting amounts because itable concerning the peptides recognized by T cells in
binds weakly, failing to induce negative selection (Gam-inbred mice bearing the class II molecule I-Ak. HEL in-
mon and Sercarz, 1989). This latter situation may beduces strong B cell and CD4 T cell responses to several
represented by the various myelin basic protein epi-of its epitopes, some of which have been well character-
topes responsible for disease in the experimental aller-ized (Allen and Unanue, 1984; Adorini et al., 1988; Good-
gic encephalitis (EAE) model of multiple sclerosis (Fair-now et al., 1988; Gammon et al., 1991).
child et al., 1993; Joosten et al., 1994; Harrington etOur laboratory has isolated several peptide families
from I-Ak molecules of antigen-presenting cells (APCs) al., 1998). Our own laboratory has observed that poor
after the processing of HEL: the predominant peptide central tolerance may be a feature distinguishing the
family encompassed a nested series centered on the class II molecule I-Ag7 of the NOD mouse model of type
core sequence 52±61. The majority of the peptides were I diabetes (Carrasco-Marin et al., 1996; Kanagawa et al.,
from residues 48 extending to residues 61, 62, or 63 1998).
(i.e., DGSTDYGILQINSR/W/W). For convenience we will Knowing the densities of the HEL epitopes involved
refer to this family as 48±62 (Nelson et al., 1992). We in the T cell response, we attempt here to make some
have also described another family of peptides starting quantitative estimates of the sensitivity of negative se-
from residue 31 or 32 and ending with residues 46±49, lection when HEL is expressed as a transgene in APCs.
presented at about 20-fold lower levels than the 48±62 We will show here that thymic tolerance or negative
epitope (Gugasyan et al., 1998). Importantly for this selection operates at the level of a few peptide-MHC
study, we also have identified two putative conformers complexes. This could be expected based on various
of the same linear peptide 48±61-I-Ak complex (Viner et approaches (Yagi and Janeway, 1990; Pircher et al.,
al., 1996). The type A conformer was produced after 1991; Vasquez et al., 1992; Sebzda et al., 1994; Kimachi
HEL was processed by APCs and the 48±62 epitope et al., 1997; Peterson et al., 1999). We will also show that
was selected by I-Ak molecules (endogenous pathway). some T cells that recognize the B conformers escape
The type B conformer was produced when the APCs negative selection and peripheralize. Our experiments
were done by quantitating the number of peptide-reac-




Table 1. A and B Conformations of HEL Peptide 48±62
APC Antigen A B
(1) Live HEL 1 2
(2) Live membrane HEL 1 2
(3) Live denatured HEL 1 1
(4) Live synthetic peptide 48±62 1 1
(5) Live tryptic peptide 46±61 1 1
(6) Live covalently-linked 48±62 1 2
(7) Live I-Ak extracted 48±62 1 1
(8) Fixed HEL 2 2
(9) Fixed 48±62 1 1
(10) Fixed denatured HEL 1 1
(11) I-Ak purified 48±62 1 1
This table summarizes the findings from our laboratory on the two
kinds of 48±62-reactive states (Viner et al., 1996; Latek and Unanue,
1999; DiPoalo and Unanue, unpublished data). The A conformer is
produced by processing of HEL (numbers 1 and 2, above); impor-
tantly, 48±62 engineered on I-A bk chain, following the study of
Kappler and Marrack's laboratory (Ignatowicz et al., 1995) induces
the A conformer but not the B (6). Type B conformer is produced
when either peptide (4, 5, 7, and 9) or denatured protein (3 and 10)
are added to live or fixed APCs. The use of fixed APC indicates that
the peptide bound to I-Ak triggers the B-reactive T cell, an indication
that the peptide does not require further internalization or pro-
cessing to yield the B state. The use of tryptic peptide, in (5), indi-
cates that the conformer is not the consequence of modifications
in the synthetic peptide. Also note that 48±62 extracted from I-Ak
after processing (1) stimulates the cells reactive with the B con-
former (7); i.e., the same peptide not recognized during HEL pro-
cessing is recognized after being offered directly to the APC.
Figure 1. Limiting Dilution Analysis of Normal and HEL Transgenic
MiceResults
(A) Limiting dilution analysis (LDA) of T cells from either a 3A9
transgenic mouse or B10.BR mouse was determined using eitherResponse of Normal Mice to HEL Immunization
HEL or concanavalin A (Con A) as the stimulatory antigen in vitro.Mice were immunized with a dose of HEL that optimally
The fraction of growth-negative wells (as determined by visual in-elicits a T cell response. We evaluated the T cell re-
spection under an inverted microscope) was plotted as a function
sponse with an LDA that identifies one of every two to of the number of T cells added per well as determined by FACS.
three responding T cells (Kelso and Glasebrook, 1984; The fraction of lymph node cells from 3A9 mice positive for the
clonotype was 16% as determined by FACS. The fraction of lymphKanagawa et al., 1998). (This sensitivity was tested using
node cells from B10.BR mice positive for CD4 or CD8 markers waseither the response of the 3A9 T cell receptor [TCR]
29%. The frequencies from the LDA were derived as described intransgenic mice to HEL or the response of T cells from
the Experimental Procedures.B10.BR mice to concanavalin A [Figure 1A].) Following
(B) LDA of B10.BR and ML-5 transgenic mice immunized with 10
immunization, each HEL-specific T cell in the analysis nmols HEL demonstrated tolerance in ML-5 mice. The fraction of
was expanded and tested against various HEL peptides negative wells was plotted as a function of the number of cells
added per well. Positive wells were identified by growth, and subse-found to elicit a T cell response. The peptides tested
quent HEL specificity was determined. The frequencies displayedare shown in Figure 2, along with their binding strength
were corrected for specificity. Each draining lymph node containedfor I-Ak. It is notable that only the 48±63 and 31±49
roughly 107 total cells. Twelve to seventeen percent of lymph nodesequences correspond to those of the natural peptide
cells were CD41 by flow cytometry; the number of CD4 cells was
(i.e., the peptides selected by I-Ak during processing of similar for all strains of mice in individual experiments. These results
HEL in APC). Whether the other peptides used corre- are representative of the one of the three experiments in Figure
2C (middle panel). There was a 76-fold decrease in HEL specificspond exactly to their natural sequences has yet to be
precursors in the ML-5 mice.determined.
(C) T cell tolerance observed in both WT-mHEL and ML-5 miceThe draining lymph nodes of B10.BR mice immunized
immunized with HEL. Precursor frequency was determined by LDAwith HEL contained 1 per 750 to 1 per 3700 HEL-specific
followed by specificity analysis. The precursor frequency for HEL
T cells (Figures 1B and 1C). The precursor frequency is immunized mice is expressed on the x axis. For example, a precursor
displayed by the bars in Figure 1C where a frequency frequency of 1 in 1000 represents 1e23 as plotted here.
of 1 in 1000 would be equal to 1e23 as shown on the x
axis. In 337 clones examined, the predominant response
was to epitopes 48±63 (31% of the clones), 18±33 (32%), to epitopes 70±88 and 98±112 represented 4% and 1%,
respectively (data not shown). Of the total respondingand 115±129 (21%) (Figure 2). The 31±49 epitope was
only 7% of the I-Ak-restricted response. Of the I-Ak- T cells, 12% was restricted by I-Ek. The epitopes for
these T cells were not examined.restricted response, the specificity of 91% of clones was
determined. The remaining 9% included the epitopes The repertoire of HEL-specific T cells in the B10.BR
may reflect the impact of the expression of the mouse70±88 and 98±112, which were not examined for all ex-
periments. When examined, we found that the response homolog murine lysozyme. This protein is expressed
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Figure 2. The Peptide Specificity of the HEL-
Specific T Cells in the B10.BR and ML-5 Mice
The bars depict the percent of the I-Ak-
restricted HEL response specific for each of
the four major epitopes of HEL. The sequence
of HEL and mouse lysozyme M (ML) peptideare
displayed next to their respective bars (amino
acid differences are highlighted in bold). The
RIC21 values, shown in parentheses, repre-
sents the relative concentration of the pep-
tide required to compete for binding of deter-
gent-soluble I-Ak by 125I-labeled reference
peptide, as described previously (Nelson et
al., 1996). Epitopes 70±88 and 98±114 were
not tested in every experiment. These are dis-
played next to the fraction of response not
specific for the four predominant peptides.
While there was a clear pattern of T cell re-
sponse, there was no major difference in the
T cell repertoire of ML-5 (solid bars) com-
pared to B10.BR (open bars). The repertoire of B10.BR and ML-5 was determined by the identification of 337 and 132 I-Ak-restricted T cells,
respectively. Twelve percent of the B10.BR response and 15% of the ML-5 response were I-Ek restricted.
normally in some APCs. Thus, it was important to exam- et al., were found to exhibit substantial tolerance of the
HEL-specific T cells (Goodnow et al., 1988; Adelstein etine the murine lysozyme peptides in terms of both their
degree of homology to HEL peptides as well as their al., 1991). HEL is produced as soluble protein under the
metallothionein promoter, circulating at about 10±20 ngbinding strength for I-Ak molecules. Most murine pep-
tides exhibit significant amino acid differences with the per milliliter of serum. It was previously reported by
Kanost et al. that the APCs of the ML-5 mice were unablecorresponding HEL sequences.
The impact of murine lysozyme epitopes on the HEL to directly present the 48±62 epitope to T cells (Kanost
et al., 1993). We observed very similar results (Figurerepertoire was difficult to observe (Figure 2). Moudgil
and Sercarz had predicted that epitopes of murine lyso- 3A), as the ML-5 APCs poorly stimulated the 3A9 T cells.
We were unable to reproducibly detect the I-Ak-48±62zyme that are not presented would correspond to HEL-
specific T cells repertoire in the nontransgenic response complex using the AW3.18 monoclonal antibody. Based
on the sensitivity of the assays used, we estimated that(Moudgil and Sercarz, 1993). However, this relationship
did not hold in these experiments. Of the murine lyso- the number of complexes of I-Ak-48±62 must be less
than 100 per APC.zyme peptides, 31±49 and 70±88 failed to bind I-Ak, and
yet they were poorly represented in the corresponding After immunization of WT-mHEL mice with HEL, we
were unable to detect any HEL-specific T cells (FigureHEL-specific T cell repertoire (Figure 2). Moreover, the
48±63 murine peptide bound to I-Ak as well as the corre- 1C). We detected a reproducible number of autoreactive
(not HEL-specific) T cells at a frequency between 1 persponding HEL peptide, yet this was a major epitope in
the B10.BR repertoire (Figure 2). 4 3 104 and 105 cells. In a representative experiment
we examined 156 growth-positive wells, 60 of whichIn summary, the binding strength of the HEL epitopes
for I-Ak does not explain the distribution of the HEL- responded to B10.BR APC in the absence of HEL, while
the remaining 96 did not respond. (If 1 out of 156 growth-specific T cell repertoire (i.e., comparing 48±63 and 115±
129 in Figure 3). The repertoire for foreign antigen must positive wells had been HEL specific, it would have
translated into a frequency of 1 per 6 3 106 cells [1.6e27],therefore reflect a complex mixture of multiple parame-
ters, of which we have only analyzed two (the impact out of lymph nodes having z107 total cells per node.)
Lastly, repeated attempts to isolate and propagate HEL-of binding and the impact of autologous protein).
reactive T cells from bulk cultures consistently failed.
Again, the only T cells that grew from such culturesResponse of HEL Transgenic Mice
to HEL Immunization were autoreactive but not HEL specific. Therefore, we
concluded that tolerance to all HEL epitopes in WT-We examined two lines of transgenic mice expressing
HEL. The wild-type HEL mice (ªWT-mHELº) express mHEL mice was complete.
In contrast to the WT-mHEL mice, we identified HEL-a membrane-bound form of HEL on all APCs. HEL-
expressing cells were found in both the thymic cortex specific T cells in the ML-5 transgenic mice immunized
with HEL, although at a much reduced frequency whenand medulla (data not shown). APCs of the WT-mHEL
mice, harvested from the peritoneal cavity or the spleen, compared to the B10.BR response (Figure 1B). This dif-
ference reflects the difference in HEL levels between thestimulated the 3A9 T cells that recognizes the 48±62
peptide family (Figure 3A). Using the AW3.18 mono- transgenic mice (Figure 3A). The precursor frequency of
HEL-reactive T cells was 77- to 127-fold lower than inclonal antibody specific for the 48±62-I-Ak complex, we
quantitated a range of 3,400±20,000 peptide-MHC com- the immunized B10.BR mice, demonstrating incomplete
tolerance.plexes per APC in the WT-mHEL mice (Dadaglio et al.,
1997) (Figure 3B; data not shown). The specificity of the T cells from immunized ML-5
mice did not differ from the immunized B10.BR miceThe ªML-5º mice, originally described by Goodnow
Immunity
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that the two HEL transgenic mice (WT-mHEL and ML-5)
completely deleted the 3A9 idiotype containing T cells,
which were also absent from spleen and lymph nodes.
These two transgenic lines differed in the extent of thy-
mocyte deletion. The ML-5/3A9 double-transgenic mice
had almost 10-fold fewer thymocytes than the 3A9 con-
trol transgenic mice. The deletion, however, was more
marked in the WT-mHEL/3A9 double-transgenic miceÐ
about 100-fold reduction in total thymocytes compared
the 3A9 control transgenic mice (Figure 4). In addition
there was a small population of CD4 and CD8 double-
positive thymocytes that persisted in the ML-5/3A9 dou-
ble-transgenic mice, while the WT-mHEL/3A9 double-
transgenic mice had none. These results indicate that
negative selection was occurring on the low number of
complexes on the APCs of the ML-5 mice. The differ-
ences between our results and those of Akkaraju et al.
may reflect either a lower level of presentation of the
48±62 epitope or inefficient positive selection on the
H-2kxb background (Tourne et al., 1999).
Figure 3. Analysis of Antigen of Presentation in HEL Transgenic
Response of HEL Transgenic MiceMice
to Peptide Immunization(A) Stimulation of 3A9 transgenic T cells by splenocytes from HEL
We analyzed the response of the HEL transgenic micetransgenic mice. Lymph node cells from 3A9 transgenic mice were
incubated with titrating numbers of splenocytes from WT-mHEL to immunization with the dominant 48±62 epitope. The
mice or ML-5 mice. Proliferation of the T cells was measured by mice were immunized with the natural tryptic peptide
[3H]thymidine incorporation. Cultures were pulsed for the last 12 hr 46±61 from HEL in order to avoid any response to con-
of 72 hr cultures. There was roughly a 100-fold difference between
taminants found in synthetic peptides (Schild et al.,WT-mHEL and ML-5 APCs.
1991; Purcell et al., 1998). However, this restricts our(B) Specific binding of the AW3.18 monoclonal antibody to spleno-
analysis to T cells that are independent of the 62/63cytes of the WT-mHEL mice. T cell±depleted splenocytes (2 3 107)
from the WT-mHEL mice were incubated with 125I-labeled AW3.18 residues as was first reported by Carson et al. (1997).
monoclonal antibody specific for the 48±62-I-Ak complex. Bound After immunization, reactive T cells against the 48±61
and unbound antibody was separated by spinning the APCs through peptide in the LDA were then examined for their reactiv-
oil. Nonlinear regression of the antibody-bound versus antibody-
ity to HEL and the peptide (Figures 5A and 5B): the Tadded antibody revealed a maximum binding of 83.9 ng/2 3 107
cells that recognized the A conformer reacted with bothAPCs (as described in the Experimental Procedures). In this experi-
HEL and the peptide, while the T cells that recognizedment, this represents 16,800 complexes per APC; Scatchard analy-
sis of the same data placed this value at 15,000 complexes per the B conformer reacted only to peptide. The reactivity
APC. Results from multiple experiments have ranged from 3,400 to of representative T cells identified in a single experiment
20,000 complexes per APC. are shown in Figure 6.
The number of 48±61 reactive T cells was reduced in
the two HEL transgenic lines, WT-mHEL and ML-5 (Fig-
(Figure 2): neither the strong nor the weak epitopes were ure 5A). In four separate experiments, the number of the
preferentially tolerized or spared. The two most preva- type B T cells accounted for about 33% of the 48±61
lent epitopes in the B10.BR response (18±33 and 48±63) response in the immunized B10.BR mice (Figure 5B). In
were the most prevalent in the ML-5 HEL-specific re- contrast, 100% of the 48±61-reactive T cells from the
sponse. Likewise, the weakest epitope, 31±49, was WT-mHEL were specific for the type B conformer (Figure
weakest in the ML-5 HEL response. Apparently all epi- 5B). Thus, the tolerance was complete for the A-reactive
topes of HEL were presented in the thymic APCs of cells but incomplete for the B-reactive ones (i.e., the
the ML-5 mice but not at levels sufficient for complete frequency of type B±specific T cells was only reduced
tolerance. between 2- and 20-fold when compared to the B10.BR
response). Thus, although the level of presentation by
APC of the 48±62 family peptides is relatively high inDevelopment of the 3A9 TCR Transgenic T Cells
in HEL Transgenic Mice the WT-mHEL mice (3,000±20,000 complexes per APC),
T cells recognizing this epitope in the type B conforma-To examine further the sensitivity of the negative selec-
tion process, we evaluated the development of T cells tion escaped tolerance.
As the ML-5 mice had a low level of response followingin the 3A9 TCR transgenic mice crossed to the different
HEL transgenic mice (Ho et al., 1994; Akkaraju et al., immunization with HEL, we predicted that there would
be a T cell response following immunization with the1997). Akkaraju et al. (1997) studied the development of
3A9 T cells in mice bearing the 3A9 transgene crossed HEL tryptic peptide 46±61. While there was a reduced
peptide-specific T cell response in the ML-5 mice, weto the ML-5 or a membrane HEL transgenic mice (under
a class I MHC promoter), both in the H-2kxb F1 haplotype. observed a differential tolerance between the type A±
and type B±reactive T cells in that the A-reactive T cellsIn their results, they observed incomplete deletion of
3A9 expressing T cells by the ML-5 mice. We observed were preferentially affected (Figure 5B).
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Figure 4. The Analysis of 3A9/HEL Double
Transgenic Mice
Thymocytes from mice of 3A9/HEL double-
transgenic was analyzed with three-color
FACS analysis for CD4, CD8, and 3A9 T cell
receptor. CD4 and CD8 expression are dis-
played in the contour plots on the left. Expres-
sion of the 3A9 T cell receptor expression
was determined using the 1G12 clonotypic
antibody for 3A9. The histograms on the right
demonstrate the clonotype expression on
CD41CD82 thymocytes. The effective dele-
tion of CD4/CD8 double-positive thymocytes
was observed in 3A9 mice crossed to the WT-
mHEL mice. In the representative experiment shown here, the total number of thymocytes was dramatically reduced in double-transgenic
mice: the 3A9 single-transgenic thymus had 1 3 108 thymocytes; the 3A9/WT-mHEL double-transgenic mice had 1.1 3 106. 3A9/ML-5 double-
transgenic mice showed a weaker deleting phenotype, with the persistence of a double-positive population and nearly 10-fold more total
thymocytes (1.4 3 107). The expression of clonotype on CD4 single-positive T cells was absent in all double-transgenic mice, indicating that
both mice effectively eliminated the 3A9 T cells.
Figure 6A shows the specificity of T cells from B10.BR, identified the escape from negative selection of particu-
lar sets of self-peptide-reactive T cells.ML-5, and WT-mHEL mice identified from LDA. Cells
from individual wells were tested on HEL or 48±61 pep- Concerning the sensitivity of negative selection, the
WT-mHEL transgenic mice were extremely effective intide. Shown in this figure is the ratio of the proliferation
to HEL (counts per minute [cpm]) to the 48±61 (cpm). inducing complete tolerance to all HEL epitopes (except
to those reflected in the type B conformers). We calcu-We set criteria for type B versus type A distinction based
on the response of the T cells to either 5 mM peptide or lated that the dominant expressed peptide, 48±62, was
present in thousands of copies per APC, a number that50 mM HEL. The density of peptide-MHC complexes
generated by 50 mM HEL was much greater than that is much higher than required for negative selection. Of
interest, however, were the results that demonstratedgenerated by 5 mM peptide as measured by the AW3.18
monoclonal antibody (data not shown). Clones that in- partial tolerance in the ML-5 mice. The APC from ML-5
mice only expressed z100 complexes of I-Ak-48±62 percorporated twice as much [3H]thymidine with peptide
as with HEL were classified as type B, and those with APC. As noted in the 3A9 transgenic mice crossed to
ML-5, this level was sufficient to entirely delete the ex-less than twice as much incorporation were classified
as type A. Thus, these criteria defined a type B±reactive pression of the 3A9 clonotype. The differences in toler-
ance between ML-5 and the 3A9/ML-5 may have to doT cell as one that preferentially responded to the lower
number of complexes formed from peptides compared with the affinity of the TCR. The 3A9 T cell probably
represents a high-affinity T cell. The T cells of similarto HEL.
While the repertoire of T cells in the B10.BR mice affinity were presumably tolerized in the ML-5 mice,
while those that escaped and identified were likely ofdemonstrated a spectrum of HEL versus peptide re-
sponsiveness, most T cells from ML-5 and WT-mHEL lower affinity (Yule et al., 1993). But the point to be
stressed is that the remaining epitopes of HEL are pre-responded better to peptide than HEL. In the T cells
cloned from WT-mHEL mice, none of the T cells reacted sented at even lower levels, given their weaker binding
strength for I-Ak. We have directly quantitated that theto 50 mM HEL with [3H]thymidine incorporation 2-fold
above background (27 clones analyzed). Figure 6B presentation of 31±49 peptide family is at about one-
twentieth the amount of 48±62 (Gugasyan et al., 1998).shows the analysis of representative clones when ex-
panded and then tested for their dose response to HEL As was demonstrated by the immunization of ML-5 mice
with HEL, the T cell response to every peptide wasand peptide. T cells in Figure 6A, which were classified
as type B by their response to 50 mM HEL and 5 mM affected equally (there was no differential tolerance).
Presumably, the higher affinity T cells specific for all ofpeptide, all demonstrated type B patterns like those
demonstrated in Figure 6B. the epitopes were eliminated. Thus, it follows that the
number of peptide-MHC complexes of some epitopes
causing negative selection of immature thymocytes areDiscussion
at the single-digit levels. We previously reported that ex
vivo negative selection of double-positive thymocytesWe addressed here the relationship between peptide
presentation and the T cell repertoire in the context of took place on APC bearing an average of only three
complexes of 48±61-I-Ak per APC (Peterson et al., 1999).central tolerance. Attempts can be made now to quanti-
tate both parameters, facilitating an objective evaluation The high sensitivity of thymic tolerance is to be ex-
pected if this tolerance represents a mechanism to elimi-of their interdependence. Three main results were ob-
tained. First, we could observe the high sensitivity of nate autoreactive T cells to blood proteins. Practically
all proteins that enter the thymus would be expected tocentral tolerance that operates at the level of a few
peptide-MHC complexes per APC. Second, we ob- tolerize. The same would apply to peptides derived from
endogenous proteins expressed in thymic APC. In ourserved equal tolerance among epitopes expressed at
different levels, allowing us to place some limits on the examples with HEL, we speculate that to observe differ-
ential tolerance, 48±62 would have to be presented at anumber required to see such an effect. Third, we have
Immunity
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al., 1998) and by our laboratory in the context of the
diabetogenic I-Ag7 molecule (Carrasco-Marin et al., 1996;
Kanagawa et al., 1998). These results indicate that these
weak interactions allow for negative selection to be im-
paired, which was documented in the studies with the
ac1±11 epitope of myelin basic protein and in the analy-
sis with I-Ag7.
We identified T cells that escaped tolerance. Immuniz-
ing the WT-mHEL transgenic mice with peptide revealed
a population of T cells specific for the type B conformer
of 48±62 (a self-peptide). This proves that there is a
population of T cells very specific for the type B con-
former of the peptide-MHC complex yet unreactive with
the type A conformer. Indeed, this set of T cells was not
affected by the extremely high levels of 48±62 peptide
present in the WT-mHEL mice (thousands of peptide-
MHC complexes/APC). The importance of this popula-
tion could be profound. They may represent an ignorant
population of self-specific T cells that, having no tem-
pering of their response as would be expected for type
A±reactive T cells, could proliferate and provide T cell
help against self-antigens (Ohashi et al., 1991).
Under what circumstances could these phenomena
be significant in autoimmunity? In the case of the T
cells reactive with a B conformation that escapes central
thymic deletion (i.e., WT-mHEL mice), it could imply that
these autoreactive T cells circulate and could be acti-
vated if they encounter a peptide-MHC complex in the
type B conformation. The activation of the uniquely spe-
cific type B T cell population would require unique cir-
cumstances akin to inflammation for their activation: (1)
the extracellular digestion of self-protein and subse-
quent loading of APCs (Accapezzato et al., 1998), (2)
the release of previously processed peptides from MHC
antigens, followed by reloading, or (3) the denaturationFigure 5. Response to 46±61 Peptide Immunization
or unfolding of a self-protein and subsequent loading(A) The LDA of mice immunized with the 46±61 peptide. B10.BR,
onto surface class II antigens. Denatured or digestedWT-mHEL (WT in the figure), and ML-5 mice (ML-5) were immunized
protein could presumably be found in sites of inflam-with 10 nmols of 46±61 HEL peptide. This figure shows the LDA of
growth-positive wells as scored on day 7. These wells were subse- mation.
quently expanded and tested for their specificity. The precursor We described in a previous report a ªbiochemical
frequencies shown in the box represent the actual frequency of margin of safetyº whereby T cells that escape negative
specific T cells after correction for the specificity analysis. selection in the thymus cannot be triggered in the pe-
(B) The precursor frequency of type A and type B T cells is repre-
riphery by the usual density of self-peptide-MHC com-sented as was described in Figure 2C. The results of four individual
plexes displayed by most APCs, but require 100-foldexperiments are shown. While type A T cells were undetectable in
more peptide-MHC complexes (Peterson et al., 1999).WT-mHEL mice, type B T cells demonstrated only a 2- to 20-fold
reduction compared to the B10.BR mice. The ML-5 mice demon- Thus, most naive T cells remain dormant, since the
strated a greater reduction in type A precursor frequency than type threshold number of peptide-MHC complexes in APC for
B precursor frequency when compared to the B10.BR mice. triggering these cells may never be realized. However, a
T cell that has been primed by previous encounter with
antigen, particularly the unique circumstances we have
very low level where the display of 31±49 was practically described for the formation of type B conformations,
absent. In this context, the 20-fold difference in the will modify its threshold of activation. This activation
abundance of these two epitopes represents a narrow now decreases to much lower numbers the T cell thresh-
range; to observe differential tolerance between two old of peptide-MHC complexes needed for triggering.
epitopes probably requires that these differences be Thus, these T cells can be activated by a low level of
much greater, i.e., 100- to 1000-fold. self-complexes. We are currently evaluating these pos-
In brief, to escape negative selection, peptide epi- sibilities.
topes would have to be absent from thymic APC or Finally, the escape of type B T cells from tolerance
expressed at single levels by weak-binding interactions should be considered in the analysis of T cells in autoim-
with class II molecules. The point of weakly binding munity and when mice are immunized with self-peptide.
peptides and tolerance was previously addressed by Indeed, considering our results revealing type B T cells
the laboratories of Wraith and Goverman with their stud- and the results of Schild et al. and Purcell et al., who
ies on the response to myelin basic protein peptides found that immunizing mice with synthetically derived
self-peptides elicited T cells specific for contaminants(Fairchild et al., 1993; Liu et al., 1995; Harrington et
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Figure 6. Characterization of T Cells from Peptide-Immunized Mice
(A) The specificity of T cell populations identified in B10.BR, ML-5, and WT-
mHEL mice immunized with 46±61 peptide. We compared the relative re-
sponse of clonal T cells to HEL (50 mM), peptide (5 mM 48±61), or no antigen.
The B10.BR repertoire displayed a wide spectrum of HEL/peptide ratios,
ranging from close to 2000 (clone farthest to the left) to 0. We chose a HEL/
peptide ratio of 50 as the cut off for classification as a type B T cell. However,
considering that the level of peptide-MHC complexes per APC is actually
greater with 50 mM HEL than 5 mM peptide, the true separation of type A
versus type B specificity may be at the inflection observed in the B10.BR
repertoire around a ratio of 125. Indeed, the type B T cells found below the
HEL/peptide ratio of 50 generally have no or very weak response to HEL
above background. Note that the background proliferation was not subtracted
and, thus, some of the HEL/peptide ratios observed were the same as the
background/48±61 ratios. As the number of T cells was not controlled during
the testing of T cells from the LDA, the maximum counts per minute of
individual T cells varied from 295 to 57,000 cpm. There was, however, no
correlation with raw counts per minute and the HEL/peptide ratio. All specific
T cells were identified by having at least twice the proliferation to antigen
compared to media controls. It is important to note that we previously ob-
served no correlation with the sensitivity of the T cells and the ratio of HEL
to 48±61 response (Viner et al., 1996).
(B) The sensitivity of T cells from the different mice. T cell clones from B10.BR
(upper panels), ML-5 (middle panels), and WT-mHEL mice (lower panels)
were tested for their dose response to 48±61 peptide (squares) and HEL
(diamonds). Clone B10.BR-B7 was taken as reactive to the A conformer. In
contrast B10.BR-A8, a typical clone reactive to the B conformer, responds
to HEL very weakly at high concentrations. The clones in the middle and
lower panels are type B reactive.
for HEL (Yule et al 1993); WT-mHEL mice were screened by FACSof the peptides, all past and future experiments involv-
analysis of peripheral lymphocytes with anti-HEL antibody F10.6.6.ing such manipulations should be examined critically
The 3A9 transgenic mice were screened by FACS analysis of lym-(Schild et al., 1991; Purcell et al., 1998). Many experi-
phocytes using the 1G12 anti-clonotype monoclonal antibody.
ments have been performed in which mice were immu- B10.BR and B10.A(4R) mice were obtained from Jackson Labora-
nized with peptides, and those in which T cells were tories and bred at the Washington University small animal facility.
unresponsive to intact antigen may need to be revisited
(Gammon and Sercarz, 1989; Cibotti et al., 1992; Ma-
Antibodiesmula, 1993; Moudgil and Sercarz, 1993; Cabaniols et
Anti-CD4 and anti-V-b 8 were purchased from Pharmingen. Anti-al., 1994; Rider et al., 1996; Barlow et al., 1998; Targoni
CD8 quantum red (QR) was purchased from Sigma Chemical. The
and Lehman, 1998). Indeed, studies like those of Wen anti-HEL-specific antibody F10.6.6 (Fischmann et al., 1988) was the
et al. may already suggest that type B±specific T cells generous gift of Dr. Roberto Poljak. 1G12 is a monoclonal antibody
can be involved in an autoimmune process (Wen et al., (IgG1 isotype) specific for the 3A9 T cell receptors. Mice were intra-
peritoneally immunized biweekly with 1±2 3 107 3A9 T cells and1998).
boosted 3 days prior to fusion by intravenous injection. Hybridomas
were made by the standard fusion techniques using splenocytes ofExperimental Procedures
the immunized CB.17 mice. Their supernatants were screened for
the ability to stimulate the 3A9 T cell hybridoma (Kanagawa, 1988).Mice
The AW3.18 monoclonal used for the quantitation of 48±62-I-Ak com-The ML-5 mice were generated by Dr. Christopher Goodnow (Good-
plexes was previously described (Dadaglio et al., 1997).now et al., 1988) and were backcrossed to B10.BR mice. The 3A9
T cell receptor transgenic mice (Ho et al., 1994) were a generous
gift from Dr. Mark Davis (Stanford University). The WT-mHEL and
Presentation of the 48±62 Epitope to 3A9 T CellsA-7 mice were generated using a cDNA gene for chimeric HEL-Ld
Titrating numbers of splenocytes from the HEL transgenic mice werefusion protein (Nelson et al., 1997) under the I-E a promoter
incubated with 1 3 104 lymph node cells per well from 3A9 transgenic(Kouskoff et al., 1993). The construct was injected into B6 oocytes
mice in 96-well U-bottom plates. Proliferation was assessed by in-and the transgenic progeny were subsequently backcrossed to the
corporation of [3H]thymidine by pulsing the cultures from days 3±4B10.BR strain. All mice were maintained at the Washington Univer-
sity small animal facility. ML-5 mice were screened by serum ELISA of the 4 day culture.
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Quantitation of 48±62 Epitope on APCs Using the AW3.18 Peptides and Peptide Binding Studies
Peptides were synthesized on a Synergy 432A peptide synthesizerMonoclonal Antibody
The antibody was iodinated using the Chloramine T method as (Applied Biosystems) or Symphony/Multiplex peptide synthesizer
(Protein Technologies). The peptides were made using the F-mocdescribed previously (Dadaglio et al., 1997). Splenocytes were T
cell depleted by complement fixation with the anti-Thy-1 antibody chemistry. Peptides were purified by reverse-phase HPLC and the
quality of each peptide was determined by mass spectrometry.(AT83A). Thy-1 depleted splenocytes (2 3 107) from the HEL
transgenic or B10.BR mice were incubated with titrating amounts The relative binding strength of each peptide was determined as
described previously (Nelson et al., 1996). Briefly, purified I-Ak fromof labeled antibody for 2 hr at 48C (in triplicate). The cells were then
spun through oil to separate bound from free antibody. Nonspecific detergent-lysed APCs was incubated with a 125I-labeled standard
peptide (sequence YEDYGILQINSR) in the presence or the absencebackground (on B10.BR splenocytes) was subtracted from the WT-
mHEL staining. The total number of sites per cell was determined of the peptides to be tested. The amount of bound standard peptide
was then determined by standard g counter following the separationby plotting the nanograms of bound antibody as a function of the
nanograms of antibody added to each reaction. The nonlinear re- of class II and free peptide on Bio-Spin-6 size exclusion chromatog-
raphy columns (Bio-Rad Laboratories). The concentrations of eachgression was performed fitting the data to the equation Y 5 Bmax*X/
(Kd 1 X), a built in equation on the computer program Graphpad peptide required to inhibit 50% of the maximum binding was com-
pared to the concentration of the cold standard peptide requiredPrism. The data fit the curve shown in Figure 1B with an R2 value
of 0.984. Once the amount of antibody bound at saturation was to inhibit 50% of the maximum binding (RIC21 5 Concentration-
50%test/ Concentration-50%reference).determined, the sites per cell were then calculated.
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LDA was done as previously reported (Kelso and Glasebrook, 1984;
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